Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
· 10/21/2026, 9:50:58 AM· 2 min read
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
Read original story →Related stories
breaking
Former TDP MLA Gunda Lakshmi Devi likely to join YSRCP on October 22
breaking
Railways floats tender for track doubling between Aduthurai and Sundaraperumal Koil
breaking
Continuing violence in Manipur an indictment of BJP’s failure of governance: Congress
breaking